Acute effect of proprotein convertase subtilisin/kexin type 9 inhibitor on oxidized low-density lipoprotein and lipid profile in patients at cardiovascular risk-Reference-Cited by-同舟云学术

Acute effect of proprotein convertase subtilisin/kexin type 9 inhibitor on oxidized low-density lipoprotein and lipid profile in patients at cardiovascular risk

Published:2023 Issue:3 Volume:73 Page:249-254
ISSN:0912-0009
Container-title:Journal of Clinical Biochemistry and Nutrition
language:en
Short-container-title:J. Clin. Biochem. Nutr.

Author:

Li Yiming¹,Sun Minni²,Li Ran¹,Dou Min¹,Dong Haozhe¹,Xue Liqi¹,Sun Guoju¹

Affiliation:

1. Department of Cardiovascular Medicine, The First Affiliated Hospital of Zhengzhou University

2. Department of Emergency Medicine, The First Affiliated Hospital of Zhengzhou University

Publisher

The Society for Free Radical Research Japan

Subject

Clinical Biochemistry,Nutrition and Dietetics,Medicine (miscellaneous)

Link

https://www.jstage.jst.go.jp/article/jcbn/73/3/73_23-45/_pdf

Reference41 articles.

1. 1 Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020; 41: 111–188.

2. 2 Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019; 73: e285–e350.

3. 3 O'Donoghue ML, Giugliano RP, Wiviott SD, et al. Long-term evolocumab in patients with established atherosclerotic cardiovascular disease. Circulation 2022; 146: 1109–1119.

4. 4 Guedeney P, Giustino G, Sorrentino S, et al. Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials. Eur Heart J 2022; 43: e17–e25.

5. 5 Badimon L, Vilahur G. LDL‐cholesterol versus HDL‐cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos. Ann N Y Acad Sci 2012; 1254: 18–32.